Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma

Perrot, A., Lauwers-Cances, V., Corre, J., Robillard, N., Hulin, C., Chretien, M.-L., Dejoie, T., Maheo, S., Stoppa, A.-M., Pegourie, B., Karlin, L., Garderet, L., Arnulf, B., Doyen, C., Meuleman, N., Royer, B., Eveillard, J.-R., Benboubker, L., Dib, M., Decaux, O., Jaccard, A., Belhadj, K., Brechignac, S., Kolb, B., Fohrer, C., Mohty, M., Macro, M., Richardson, P. G., Carlton, V., Moorhead, M., Willis, T., Faham, M., Anderson, K. C., Harousseau, J.-L., Leleu, X., Facon, T., Moreau, P., Attal, M., Avet-Loiseau, H., Munshi, N.
American Society of Hematology (ASH)
Published 2018